Evidence map›Paper›PMID 32441096›Full record

ArticleJournal of proteome research2020

New Enzymatic Approach to Distinguish Fucosylation Isomers of N-Linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry.

Connor A West, Hongyan Liang, Richard R Drake, Anand S Mehta

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Protein N -Glycans in Healthy and Sclerotic Glomeruli in Diabetic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Connor A WestDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Basic Science Building 358, Charleston South Carolina 29425, United States.
Hongyan LiangDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Basic Science Building 358, Charleston South Carolina 29425, United States.
Richard R DrakeDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Basic Science Building 358, Charleston South Carolina 29425, United States.
Anand S MehtaDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Basic Science Building 358, Charleston South Carolina 29425, United States.ORCID 0000-0002-9846-9389
Medical University of South Carolina · US

Funding

Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Sociobiological Responses to Stress in Prostate Cancer SurvivorsU54MD010706 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ETHIER, STEPHEN P., HUGHES-HALBERT, CHANITA A. · 2016 to 2020
$8.0M
Predicting HCC through GlycomicsR01CA120206 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MEHTA, ANAND S. · 2006 to 2016
$4.3M
Glycopathology of HCC: identification of the source cells of serum fucosylationU01CA226052 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DRAKE, RICHARD R., HOSHIDA, YUJIN · 2019 to 2023
$2.8M
Translation of a biomarker panel for the early detection of hepatocellular carcinomaR01CA237659 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARRERO, JORGE A, MEHTA, ANAND S. · 2019 to 2023
$2.5M
Aberrantly secreted glycoproteins as markers of liver cancerU01CA168856 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MEHTA, ANAND S. · 2012 to 2016
$1.5M
NCI NIH HHS R01 CA120206NCI NIH HHS R01 CA237659NCI NIH HHS U01 CA168856NCI NIH HHS U01 CA226052NIDDK NIH HHS P30 DK123704NIMHD NIH HHS U54 MD010706
6 · The paper itself

Abstract

Specific alterations in N-linked glycans, such as core fucosylation, are associated with many cancers and other disease states. Because of the many possible anomeric linkages associated with fucosylated

Indexed as

AcetylglucosaminePolysaccharidesGlycosylationHumansMaleMannosyl-Glycoprotein Endo-beta-N-AcetylglucosaminidaseSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAcetylglucosamineMannosyl-Glycoprotein Endo-beta-N-AcetylglucosaminidasePolysaccharidesdual Enzymeendoglycosidase F3, Endo F3MALDImass apectrometry imagingN-glycansN-glycosylationPNGase F

Identifiers

PMID32441096
PMCPMC8908332
OpenAlexW3026403478

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.